1. Lu, J. et al. Prevalence, awareness, treatment, and control of hypertension in China: data from million adults in a population-based screening study (China PEACE Million Persons Project). Lancet 390, 2549-2558 (2017).
2. Bakris, G. & Sorrentino, M. Redefining Hypertension - Assessing the New
Blood-Pressure Guidelines. N Engl J Med 378, 497-499 (2018).
3. Yang, C. et al. Prevalence and treatment of hypertension in China: impacts of 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. Sci Bull 63, 488-493 (2018).
4. Selye H. The evolution of the stress concept. Stress and cardiovascular disease. Am J Cardiol 26, 289-299 (1970).
5. Whitworth, J. A., Kelly, J. J., Brown, M. A., Williamson, P. M. & Lawson, J. A. Glucocorticoids and hypertension in man. Clin Exp Hypertens 19, 871-884 (1997).
6. Whitworth, J. A., Brown, M. A., Kelly, J. J. & Williamson, P. M. Mechanisms of cortisol-induced hypertension in humans. Steroids 60, 76-80 (1995).
7. Whitworth, J. A., Brown, M. A., Kelly, J. J. & Williamson, P. M. Experimental studies on cortisol-induced hypertension in humans. J Hum Hypertens 9, 395-399 (1995).
8. Arena, R. et al. Healthy lifestyle interventions to combat noncommunicable disease-a novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine. Eur Heart J 36, 2097-2109 (2015).
9. Pazoki R, Dehghan A, Evangelou E, et al. Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations With Midlife Blood Pressure Levels and Cardiovascular Events. Circulation 137, 653-661 (2018).
10. Carey, R. M., Muntner, P., Bosworth, H. B. & Whelton, P. K. Prevention and Control of Hypertension: JACC Health Promotion Series. J Am Coll Cardiol 72, 1278-1293 (2018).
11. Juraschek, S. P., Miller, E. R. 3rd., Weaver, C. M. & Appel, L. J. Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure. J Am Coll Cardiol 70, 2841-2848 (2017).
12. Bakris, G., Ali, W. & Parati, G. ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline Comparison. J Am Coll Cardiol 73, 3018-3026 (2019).
13. Hu, C. Grants supporting research in China. Eur Heart J 39, 2342-2344 (2018).
14. Hu, C. S. & Tkebuchava, T. New “P” in Medical Model. Chin Med J (Engl) 129, 492-493 (2016).
15. Hu, C. S. & Tkebuchava, T. SEEDi1.0–3.0 strategies for major noncommunicable diseases in China. J Integr Med 15, 265-269 (2017).
16. Hu, C. S., Tkebuchava, T., Wu, Q. H. & Hu, D. Y. C-type hypertension: an ignored new killer? Cardiology Plus 2, 1-4 (2017).
17. Hu, C. C-type Hypertension. Eur Heart J 40, 715 (2019).
18. Hu, C. S., Wu, Q. H., Hu, D. Y. & Tkebuchava, T. Novel strategies halt cardiovascular, diabetes, and cancer strips. Chronic Dis Transl Med 3, 159-164 (2017).
19. Hu, C. & Tkebuchava, T. E-noise: An increasingly relevant health risk. J Integr Med 17, 311-314 (2019).
20. Appleton, S. L. et al. Hypertension Is Associated With Undiagnosed OSA During Rapid Eye Movement Sleep. Chest 150, 495-505 (2016).
21. Nemeroff, C. B. & Goldschmidt-Clermont, P. J. Heartache and heartbreak--the link between depression and cardiovascular disease. Nat Rev Cardiol 9, 526-539 (2012).
22. Du, H. et al. China Kadoorie Biobank Study. China Kadoorie Biobank Study. China Kadoorie Biobank Study. Fresh Fruit Consumption and Major Cardiovascular Disease in China. N Engl J Med 374, 1332-1343 (2016).
23. Denton, D. et al. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1, 1009-1016 (1995).
24. Bowman, T. S., Gaziano, J. M., Buring, J. E. & Sesso, H. D. A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol 50, 2085-2092 (2007).
25. Wang, T. et al. Improving adherence to healthy dietary patterns, genetic risk, and long term weight gain: gene-diet interaction analysis in two prospective cohort studies. BMJ 360, j5644 (2018).
26. Buendia JR, Li Y, Hu FB, et al. Long-term yogurt consumption and risk of incident hypertensionin adults. J Hypertens 36, 1671-1679 (2018).
27. Sotos-Prieto, M. et al. Association of Changes in Diet Quality with Total and Cause-Specific Mortality. N Engl J Med 377, 143-153 (2017).
28. Hu, C. S., Wu, Q. H. & Hu, D. Y. Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications. J Thorac Dis 6, 1319-1328 (2014).
29. Inoue, K., Hashioka, S., Takeshita, H., Kamura, M. & Fujita, Y. High Serum Cortisol Levels as a Potential Indicator for Changes in Well-Regulated Daily Life among Junior High School Students. Tohoku J Exp Med 249, 143-146 (2019).
30. Furuhashi, N. et al. Serum cortisol levels in pregnancy induced hypertension patients. Tohoku J Exp Med 149, 21-24 (1986).
31. Stuart, J. J. et al. Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study. Ann Intern Med 169, 224-232 (2018).
32. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 136, 493-503 (2002).
33. Gordon, N. F. et al. Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia. Am J Cardiol 94, 1558-1561 (2004).
34. Elmer, P. J. et al. PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 144, 485-495 (2006).
35. LeFevre, M. L. U.S. Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 161, 587-593 (2014).
36. Janke, E. A., Richardson, C. & Schneider, K. L. Society of Behavioral Medicine Executive Committee. Beyond Pharmacotherapy: Lifestyle Counseling Guidance Needed for Hypertension. Ann Intern Med 170, 195-196 (2019).
37. Gee, M. E. et al. Prevalence of, and barriers to, preventive lifestyle behaviors in hypertension (from a national survey of Canadians with hypertension). Am J Cardiol 109, 570-575 (2012).
38. Yao, D. K., Su, W., Zheng, X. & Wang, L. X. Knowledge and Understanding of
Hypertension Among Tibetan People in Lhasa, Tibet. Heart Lung Circ 25, 600-606 (2016).
39. Thanassoulis, G. et al. Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the Framingham Heart Study. Circulation 125, 2836-2843 (2012).
40. Luitingh, T. L. et al. A Cross-Sectional Study of the Prevalence of Exercise-Induced Hypertension in Childhood Following Repair of Coarctation of the Aorta. Heart Lung Circ 28, 792-799 (2019).
41. Cheung, B. M. et al. 2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population. Hong Kong Med J 23, 191-201 (2017).
42. Leung, G. M. & Lam, K. S. Diabetic complications and their implications on health care in Asia. Hong Kong Med J 6, 61-68 (2000).
43. Yu, H. et al. Initiating Characteristics of Early-onset Type 2 Diabetes Mellitus in Chinese Patients. Chin Med J (Engl) 129, 778-784 (2016).
44. Hjelstuen, A., Anderssen, S. A., Holme, I., Seljeflot, I. & Klemsdal, T. O. Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives. Scand Cardiovasc J 41, 313-320 (2007).
45. Bolbrinker, J., Zaidi Touis, L., Gohlke, H., Weisser, B. & Kreutz, R. European guidelines on lifestyle changes for management of hypertension: Awareness and implementation of recommendations among German and European physicians. Herz 43, 352-358 (2018).
46. Li, G. et al. Effects of guideline-based hypertension management in rural areas of Guangdong Province. Chin Med J (Engl) 128, 799-803 (2015).
47. Sio, S. D. et al. Work-related stress and cortisol levels: is there an association? Results of an observational study. Eur Rev Med Pharmacol Sci 22, 9012-9017 (2018).
48. Jones, C. & Gwenin, C. Cortisol level dysregulation and its prevalence-Is it nature's alarm clock? Physiol Rep 8, e14644 (2021).
49. Tan, T. et al. Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol 8, 659-660 (2020).
50. Hamrahian, A. H., Oseni, T. S. & Arafah, B. M. Measurements of serum free cortisol in critically ill patients. N Engl J Med 350, 1629-1638 (2004).
51. Akishita, M. et al. Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors. Atherosclerosis 210, 232-236 (2010).
52. Estrada-Y-Martin, R. M. & Orlander, P. R. Salivary cortisol can replace free serum cortisol measurements in patients with septic shock. Chest 140, 1216-1222 (2011).
53. Lazzarino, A. I., Hamer, M., Gaze, D., Collinson, P. & Steptoe, A. The association between cortisol response to mental stress and high-sensitivity cardiac troponin T plasma concentration in healthy adults. J Am Coll Cardiol 62, 1694-1701 (2013).
54. Lee, D. Y., Kim, E. & Choi, M. H. Technical and clinical aspects of cortisol as a biochemical marker of chronic stress. BMB Rep 48, 209-216 (2015).
55. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345, 941-947 (2001).
56. Wechsler, M. E. et al. NHLBI AsthmaNet. Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. N Engl J Med 381, 1227-1239 (2019).